$2.23
-0.06-2.40%
At close: -
$2.23
-0.00630-0.28%
After Hours: May 6, 6:49 PM EDT
Comments
Loading...
CytoMed Therapeutics Stock Guidance | NASDAQ:GDTC | Benzinga
CytoMed Therapeutics issues guidance on future EPS and revenue, giving investors insight into how much the company expects to earn in upcoming periods.
| Get Alert | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
CytoMed Therapeutics Ltd (GDTC) does not provide guidance data | ||||||||||||
FAQ
What is the most recent guidance for CytoMed Therapeutics (GDTC)?
There have been no specific sales or earnings guidance reported for CytoMed Therapeutics in recent months.
Browse guidance and forecast on all stocks.
